Literature DB >> 2571485

Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivity.

M L Dahl-Puustinen1, E Dumont, L Bertilsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571485

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  6 in total

1.  Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.

Authors:  C Nordin; L Bertilsson; M L Dahl; B Resul; G Toresson; F Sjöqvist
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Stereoselective glucuronidation of formoterol by human liver microsomes.

Authors:  M Zhang; J P Fawcett; J M Kennedy; J P Shaw
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

3.  Differential localisation of UDP-glucuronosyltransferase in kidney during human embryonic and fetal development.

Authors:  R Hume; M W Coughtrie; B Burchell
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 4.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 5.  Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.

Authors:  C Nordin; L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 6.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.